An economic evaluation of beta interferon therapy collected quality of life data from 62 people with relapsing-remitting multiple sclerosis, currently in remission. Each completed a postal questionnaire consisting of the Euroqol EQ-5D questionnaire, the MSQOL-54 (a disease-specific measure...

Background: The National Institute for Health and Care Excellence (NICE) emphasises that cost-effectiveness is not the only consideration in health technology appraisal and is increasingly explicit about other factors considered relevant. Observing NICE decisions and the evidence considered in...

ABSTRACT This paper describes the development of a methodology for the case‐mix adjustment of patient‐reported outcome measures (PROMs) data permitting the comparison of outcomes between providers on a like‐for‐like basis. Statistical models that take account of provider‐specific...

Patterns of self-reported morbidity and general practitioner (GP) utilization exhibit complex age, sex and time heterogeneity. Underlying patterns are often obscured by data which are overly 'rough' because of noise associated with adjacent year fluctuations. In this paper we describe methods to...

HASH(0x1009b7638)